A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Name: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
Published: 2020
License: Public Domain

Corcept Therapeutics · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

mental-disorders obesity schizophrenia weight-gain

antipsychotic-induced weight gain (aiwg), obesity, weight gain, mental disorders, schizophrenia, risperidone, paliperidone, quetiapine, olanzapine, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Related documents